View this email in your browser
Share Share
Tweet Tweet
Forward Forward


Bringing you our latest news, features and guidance.
March 2022
COVID-19NewsGet involved | Blogs | Events | Other resources | Announcements


Updates to managing COVID-19 guideline

We have added recommendations on:

We have also updated our existing recommendations on:
We are continuously updating our COVID-19 guidelines to incorporate the latest evidence and keep abreast of new developments in diagnosing and treating COVID-19. We’ll highlight recent updates in this monthly email communication, or you can keep up to date on the latest live changes through our website.


Pregnant woman holding her belly

Fetal alcohol spectrum disorder quality standard

Our latest quality standard on fetal alcohol spectrum sets out how health and care services can improve diagnosis, assessment, and prevention in 5 key areas: advice on avoiding alcohol in pregnancy; fetal alcohol exposure; referral for assessment; neurodevelopmental assessment and management plans.

Woman coughing

New lung cancer treatment recommended within Cancer Drugs Fund

We have recommended sotorasib for treating mutation-positive locally advanced or metastatic non-small-cell lung cancer in adults. This is the first new technology to come through the Innovative Licensing and Access Pathway and receive a positive recommendation from NICE. Over 500 people in England are now eligible to receive this treatment in 2022 through the Cancer Drugs Fund.

Neonatal parenteral nutrition quality standard

We’ve published a new quality standard on neonatal parenteral nutrition (intravenous feeding). It covers babies born preterm, up to 28 days after their due birth date, and babies born at term, up to 28 days after their birth. The quality standard advises neonatal parenteral nutrition is delivered through infusion sets, syringes and standardised bags that are protected from light. It also says that healthcare professionals should have access to a specialist nutritional multidisciplinary team.
This quality standard builds on our existing guideline on neonatal parenteral nutrition.

Elosulfase alfa recommended for rare life-limiting metabolic disorder

We have published draft guidance recommending elosulfase alfa for the treatment of mucopolysaccharidosis type 4A (also known as MPS 4A and Morquio A syndrome). Our positive recommendation follows the collection of real-world data from 69 people who received NHS-funded treatment as part of a managed access agreement. This enabled new evidence to be presented showing some long-term benefits of elosulfase alfa slowing the progression of MPS 4A.

Catch up on our latest news

Integrated health and care services for people experiencing homelessness

This latest episode of our NICE Talks podcast focuses on our recently published guideline on homelessness. Our guests are Guillermo Rodriguez-Guzman, head of evidence and data at the Centre for Homelessness Impact and Rachel Johns, deputy regional director at the Office for Health Improvement and Disparities and chair of our guideline committee on the topic.

Get involved

Have your say on our quality standard on indoor air quality

Help shape our quality standard on indoor air quality at home. It covers residential buildings including nursing homes, care homes and children’s homes.
The draft standard sets out that healthcare professionals should ask people with respiratory conditions or cardiovascular conditions who have repeated or worsening respiratory symptoms about their housing conditions.
Consultation is open until Monday 11 April.

Respond to our indoor air quality consultation

Comment on a consultation

Our current consultations include:

Consultation is a key part of our guidance development process. It enables those with an interest in our guidance to comment at specific stages and feedback into the decision-making process.
See all our open consultations

Join a committee

We have a number of vacancies for health, public health and lay people to join our committees. Topics include maternal and child nutrition, antenatal care and alcohol-use disorders. Join us and have an active role in producing a guideline or quality standard.

See all our committee vacancies

Observe a meeting

We’re currently holding all our public meetings virtually. You'll need to register in advance to join. 

Upcoming public meeting:

  • Friday 22 April 2022 – Medical technology advisory committee
    Registration closes Wednesday 13 April 2022.
    Agenda and register
Our advisory committee meetings, technology appraisal appeal hearings and public board meetings are open to the public. Holding them in public supports our commitment to having processes in place that are rigorous, open, and transparent.
See all our public meetings


Pilar Pinilla-Dominguez

International collaboration - building strong and resilient health and care systems through evidence-based decision-making

Pilar Pinilla-Dominguez, associate director of NICE International, reveals how NICE, through its global collaborations and partnerships, aims to contribute to improvements in health and care outcomes around the world. She also outlines plans to bring these learnings and benefits back to NICE, the NHS and the wider UK health and care system.

Read more of our latest blog posts


Methods research priorities: continuing the journey

Join our virtual event to learn more about:

  • our methods research priorities
  • our ongoing research, undertaken in collaboration with partners in the UK and across Europe
  • how our research is supporting the delivery of our 5-year strategy.

Thursday 31 March, 11am to 12:15pm.

Methods research helps NICE to keep improving the methods we use to produce guidance. It also helps us anticipate and adapt to innovative new health technologies and treatments, policy developments and changes in health and social care delivery. We're actively involved in this type of research and currently working on 10 priority research topics.

Register for your free ticket

Other resources

Building an evidence standards framework for artificial intelligence-enabled digital health technologies

In this Lancet article, we outline our work to develop an evidence standards framework for artificial intelligence-enabled digital health technologies. The framework is a set of universal standards describing the evidence requirements of different types of digital health technologies. It:

  • makes it easier for innovators and commissioners to understand what good levels of evidence for digital health technologies look like
  • helps commissioners make more informed and consistent decisions when purchasing digital health technologies
  • helps innovators understand how to demonstrate the effectiveness and value of their product when submitting their technology for NICE evaluation or selling directly to the NHS.
Read The Lancet article


the BNS app screenshot

BNF app introduces login and favourites functionality

The BNF app has introduced a new favourites functionality. It allows registered users to log in and bookmark drug monographs, treatment summaries and other records referred to frequently. Users can now easily find and quickly access this content across multiple devices.
To support the new feature, registration is now mandatory. It is quick and easy to do and once logged in, you will stay signed in on your device.

Changes to our privacy notice

We’ve made some changes to our privacy notice. Through regular newsletters and ad-hoc email communications, we’ll continue to send you the latest news, updates and information from NICE.
For more information about how we process your personal data, please see our privacy notice.

Read privacy notice

unsubscribe from this list